Search Results 8611-8620 of 42287 for oral

  1. A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders - Mayo Clinic

    ... oral or intravenous steroids at doses over 20 mg a day for over 21 days. Participating Mayo Clinic locations. Study statuses change often. Please contact the ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  4. Publications - Alyssa M. Larish, M.D. - Mayo Clinic

    Oral Oncol. 2023 Nov; 146:106568 Epub 2023 Sept 16. View PubMed; Dinoi G, Multinu F, Yost K, AlHilli M, Larish A, Langstraat C, Kumar A, Weaver AL, McGree M ...

  5. Valproate sodium (intravenous route) - Side effects & uses - Mayo Clinic

    You will be switched to an oral medicine that works the same way. If you have any concerns about this, talk to your doctor. Back to top. Precautions. It is ...

  6. Transoral robotic surgery (TORS) helps surgeons treat head and neck cancers once considered inoperable - Mayo Clinic

    Oral cavity cancer; Oropharyngeal cancer; Salivary gland cancer. During TORS, a surgeon uses robotic instruments within a single port along with a computer ...

  7. Olanzapine (intramuscular route) - Side effects & uses - Mayo Clinic

    Your doctor may give you a few doses of this medicine until your condition improves, and then switch you to an oral medicine that works the same way. If you ...

  8. Cardiovascular Medicine - Clinical trials

    ... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...

  9. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Ability to swallow and retain oral medication. Female subjects who are not of child-bearing potential, and female subjects of child-bearing potential who ...

  10. New technique prevents reservoir migration during penile prosthesis surgery - Mayo Clinic

    Recent American Urological Association (AUA) guideline changes now encourage men and providers to consider penile implant surgery after oral medications and ...